JBJ Investment Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$608K Sell
2,703
-885
-25% -$187K 0.13% 38
2021
Q3
$763K Hold
3,588
0.16% 35
2021
Q2
$875K Sell
3,588
-949
-21% -$233K 0.18% 33
2021
Q1
$1.13M Sell
4,537
-997
-18% -$238K 0.25% 28
2020
Q4
$1.27M Sell
5,534
-925
-14% -$213K 0.29% 28
2020
Q3
$1.64M Buy
6,459
+941
+17% +$233K 0.43% 25
2020
Q2
$1.3M Buy
5,518
+4,336
+367% +$989K 0.37% 31
2020
Q1
$240K Sell
1,182
-54
-4% -$11.8K 0.09% 38
2019
Q4
$298K Buy
1,236
+92
+8% +$20.3K 0.09% 38
2019
Q3
$221K Buy
+1,144
New +$220K 0.07% 45
2019
Q2
Sell
-200
Closed -$38K 59
2019
Q1
$38K Buy
+200
New +$38.2K 0.01% 103

Other funds holding AMGN

JBJ Investment Partners's AMGN Position: Q4 2021 in Review

JBJ Investment Partners reduced its Amgen (AMGN) stake by 25% in Q4 2021, selling an estimated $187K and leaving 2,703 shares worth $608K. The position accounts for 0.13% of the portfolio, ranked #38.

JBJ Investment Partners first reported a position in AMGN in Q1 2019 and has held it in 11 quarters since. The position peaked at $1.64M in Q3 2020. 2,293 funds tracked by Wall St. Rank hold AMGN as of Q4 2021.

  • JBJ Investment Partners held 2,703 shares of Amgen worth $608K as of Q4 2021.
  • JBJ Investment Partners sold 885 Amgen shares in Q4 2021, an estimated $187K.
  • Amgen made up 0.13% of JBJ Investment Partners's portfolio in Q4 2021, its #38 holding.
  • JBJ Investment Partners first reported a position in Amgen in Q1 2019 and has held it in 11 quarters since.
  • JBJ Investment Partners's Amgen position peaked at $1.64M in Q3 2020.
  • 2,293 funds tracked by Wall St. Rank held Amgen as of Q4 2021.

Based on JBJ Investment Partners's 13F filing for Q4 2021, filed 8 Feb 2022.